Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Genprex Inc. GNPX

"Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells and modulates the immune response against c

View modes: 

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces P

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference   Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) today...read more

NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Pioneerin

NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Pioneering Use of Non-Viral Vector Delivery for Gene Therapy Validated by Additional Industry Research   Clinical-stage gene therapy company...read more

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Highlighted

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Highlighted in Editorial on Potential Breast Cancer Treatments   Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning...read more

Gene Therapies with Potential to Conquer Tough-to-Tackle Bre

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers   NetworkNewsWire Editorial Coverage: Advances in biotechnology look to deliver promising new treatment options against...read more

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO to Pres

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO to Present Via Webcast at September 19 Singular Research Midwestern Values Conference   Clinical-stage gene therapy company Genprex...read more

NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) TUSC2 Fou

NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) TUSC2 Found to Prevent Tumor Growth in Triple-Negative Breast Cancer by Independent Researchers   Clinical-stage gene therapy company...read more

×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.